Minerva Surgical Stock Forecast, Price & News

Minerva Surgical (NASDAQ:UTRS) Frequently Asked Questions

Is Minerva Surgical a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Minerva Surgical in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Minerva Surgical stock.
View analyst ratings for Minerva Surgical or view top-rated stocks.

What price target have analysts set for UTRS?

4 brokers have issued 12-month price objectives for Minerva Surgical's shares. Their forecasts range from $14.00 to $17.00. On average, they anticipate Minerva Surgical's stock price to reach $15.75 in the next year. This suggests a possible upside of 150.4% from the stock's current price.
View analysts' price targets for Minerva Surgical or view top-rated stocks among Wall Street analysts.

Who are some of Minerva Surgical's key competitors?

Some companies that are related to Minerva Surgical include 4D Molecular Therapeutics (FDMT), Forma Therapeutics (FMTX), Cara Therapeutics (CARA), Inogen (INGN), Chinook Therapeutics (KDNY), OraSure Technologies (OSUR), ATI Physical Therapy (ATIP), Lexicon Pharmaceuticals (LXRX), Silence Therapeutics (SLN), Advanced Medical Solutions Group (AMS), Affimed (AFMD), Atea Pharmaceuticals (AVIR), Emisphere Technologies (EMIS), 908 Devices (MASS) and CryoLife (CRY).
View all of UTRS's competitors.

When did Minerva Surgical IPO?

(UTRS) raised $100 million in an IPO on Friday, October 22nd 2021. The company issued 6,250,000 shares at $15.00-$17.00 per share.

What is Minerva Surgical's stock symbol?

Minerva Surgical trades on the NASDAQ under the ticker symbol "UTRS."

When does Minerva Surgical's quiet period expire?

Minerva Surgical's quiet period expires on Wednesday, December 1st. Minerva Surgical had issued 6,250,000 shares in its public offering on October 22nd. The total size of the offering was $75,000,000 based on an initial share price of $12.00. During Minerva Surgical's quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Minerva Surgical?

Shares of UTRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Minerva Surgical's stock price today?

One share of UTRS stock can currently be purchased for approximately $6.29.

How much money does Minerva Surgical make?

Minerva Surgical has a market capitalization of $179.69 million.

How many employees does Minerva Surgical have?

Minerva Surgical employs 2,021 workers across the globe.